Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Gentian Diagnostics ASA ( (DE:6FK) ) has issued an announcement.
Gentian Diagnostics ASA announced that its CEO, Matti Heinonen, has purchased 5,000 shares of the company at a price of NOK 54.86 per share, increasing his total holdings to 5,000 shares and 100,000 options. This transaction, disclosed in compliance with EU Market Abuse Regulation and Norwegian Securities Trading Act, may signal confidence in the company’s future prospects and could influence investor sentiment.
More about Gentian Diagnostics ASA
Average Trading Volume: 7,780
Current Market Cap: NOK817.4M
Find detailed analytics on 6FK stock on TipRanks’ Stock Analysis page.